Skip to main content
. 2022 Nov 25;28(3):278–e166. doi: 10.1093/oncolo/oyac233

Table 1.

Proportion of participants requiring high-dose morphine and oxycodone on day 0 (n = 139).

Variable High-dose Low-dose P-value
Morphine (GG) no. (%) 14 (48.3) 15 (51.7) P = .029
Oxycodone (GG) no. (%) 6 (20.0) 24 (80.0)
Morphine (Non-GG) no. (%) 17 (41.5) 24 (58.5) P = .098
Oxycodone (Non-GG) no. (%) 9 (23.1) 30 (76.9)